IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,814,996 | -4.8% | 62,059 | -13.9% | 0.07% | -23.7% |
| Q2 2023 | $2,956,581 | -23.0% | 72,059 | -33.0% | 0.09% | -21.2% |
| Q1 2023 | $3,841,657 | -99.8% | 107,489 | +97.2% | 0.12% | +156.5% |
| Q3 2022 | $2,410,000,000 | +5.8% | 54,497 | -11.4% | 0.05% | +39.4% |
| Q2 2022 | $2,277,000,000 | -34.6% | 61,497 | +6.7% | 0.03% | -66.7% |
| Q4 2019 | $3,482,000,000 | – | 57,636 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |